Obalon Therapeutics Unternehmenskultur

Mr. William J. Plovanic, CFA has been Chief Financial Officer at Obalon Therapeutics, Inc. since March 2016 and also serves as its Secretary. Mr. Plovanic serves as the Managing Director and Research Analyst of Canaccord Genuity Limited, Research Division. He served as Managing Director of Medical Technology Equity Research at Canaccord Genuity Inc. from February 2007 to March 2016. Mr. Plovanic served as Managing Director of Equity Research at First Albany Capital Inc. from February 2001 to February 2007. He was an Equity Analyst at Broadpoint Capital Inc., Research Division, Investec Securities Ltd., Research Division, Gleacher & Company, Inc., Research Division and Hamilton Investments Inc., Research Division. He was employed at Investec Bank Limited (SA), Research Division. Mr. Plovanic holds a B.S. from Bradley University and is a CFA charterholder.

Mr. Mark C. Brister has been Chief Technology Officer at Obalon Therapeutics, Inc. since November 1, 2016 and served as its Vice President of Research & Development since June 2008 until November 1, 2016. Mr. Brister served as Vice President of Research and Development at Arterial Vascular Engineering Inc., since January 1998 and previously served as a Senior Manufacturing Engineer since November 1993. He held various positions with Advanced Cardiovascular Systems, Inc. He served as Vice President of Metal Technology of Medtronic Vascular, Inc. from 1993 to 2003. He served as Vice President of Advanced Development Teams of DexCom, Inc., from May 2003 to March 31, 2008 and its Vice President of R&D. He served as Vice President, Peripheral Products and Vice President Vascular R&D of Medtronic Inc. Mr. Brister was a Consultant of DexCom, Inc. from March 2008 to September 2008. He served as an engineer with PSG. Mr. Brister studied at the University of California at Riverside.

Bob Mondore serves as the Vice President Operations of Obalon Therapeutics. Bob started at Obalon Therapeutics in Apr of 2018. Bob currently resides in the Greater San Diego Area.

Adlai Howe serves as the Vice President Global Sales of Obalon Therapeutics. Adlai started at Obalon Therapeutics in Apr of 2012. Adlai currently resides in the Greater San Diego Area.

Todd Wood serves as the Vice President Global Sales of Obalon Therapeutics. Todd started at Obalon Therapeutics in May of 2018. Todd currently resides in the Orange County, California Area.

Bill Plovanic serves as the Chief Financial Officer of Obalon Therapeutics. Bill started at Obalon Therapeutics in Mar of 2016. Bill currently resides in the Greater San Diego Area.

Amy VandenBerg serves as the Chief Clinical & Regulatory Officer of Obalon Therapeutics. Amy currently resides in the Greater San Diego Area.

Don Young serves as the Vice President Quality Assurance of Obalon Therapeutics. Don currently resides in the Greater San Diego Area.